Identification of Psychosis Risk and Diagnosis of First-Episode Psychosis: Advice for Clinicians

References

• GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137–150. doi:10.1016/S2215-0366(21)00395-3
   PubMed Web of Science ®Google Scholar
• Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study. Lancet Glob Health. 2015;3(11):e712–723. doi:10.1016/S2214-109X(15)00069-8
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-V. 5th ed. American Psychiatric Association; 2013.
   Google Scholar
• Lysaker PH, Lysaker JT. Narrative Structure in Psychosis: schizophrenia and Disruptions in the Dialogical Self. Theory Psychol. 2002;12(2):207–220. doi:10.1177/0959354302012002630
   Web of Science ®Google Scholar
• Tandon R, Nasrallah HA, Schizophrenia KMS. “just the facts” 4. Clinical features and conceptualization. Schizophr Res. 2009;110(1–3):1–23. doi:10.1016/j.schres.2009.03.005
   PubMed Web of Science ®Google Scholar
• Arnett JJ. Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–480. doi:10.1037/0003-066X.55.5.469
   PubMed Web of Science ®Google Scholar
• Moe AM, Breitborde NJK. Psychosis in Emerging Adulthood: phenomenological, Diagnostic, and Clinical Considerations. Evid Based Pract Child Adolesc Ment Health. 2019;4(2):141–156. doi:10.1080/23794925.2018.1509032
   Google Scholar
• Liberman RP, Kopelowicz A, Ventura J, Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int Rev Psychiatry. 2002;14(4):256–272. doi:10.1080/0954026021000016905
   Web of Science ®Google Scholar
• Lieberman JA, Perkins D, Belger A, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol Psychiatry. 2001;50(11):884–897. doi:10.1016/s0006-3223(01)01303-8
   PubMed Web of Science ®Google Scholar
• McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull. 1988;14(4):515–542. doi:10.1093/schbul/14.4.515
   PubMed Web of Science ®Google Scholar
• Barrett EA, Sundet K, Faerden A, et al. Suicidality before and in the early phases of first episode psychosis. Schizophr Res. 2010;119(1–3):11–17. doi:10.1016/j.schres.2010.03.022
   PubMed Web of Science ®Google Scholar
• Kane JM, Robinson DG, Schooler NR, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program. Am J Psychiatry. 2016;173(4):362–372. doi:10.1176/appi.ajp.2015.15050632
   PubMed Web of Science ®Google Scholar
• Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975–983. doi:10.1001/archpsyc.62.9.975
   PubMed Web of Science ®Google Scholar
• Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2014;205(2):88–94. doi:10.1192/bjp.bp.113.127753
   PubMed Web of Science ®Google Scholar
• Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785–1804. doi:10.1176/appi.ajp.162.10.1785
   PubMed Web of Science ®Google Scholar
• Birchwood M, Todd P, Jackson C. Early intervention in psychosis. The critical period hypothesis. Br J Psychiatry Suppl. 1998;172(S33):53–59. doi:10.1192/S0007125000297663
   PubMedGoogle Scholar
• Kontis D, Theochari E, Giannoulis A, Louki F, Tsaltas E. T92. Possible Combinations Of DSM-IV and DSM-5 Criteria In Schizophrenia And Schizoaffective Disorder Versus Major Depressive And Manic Episodes. Schizophr Bull. 2020;46(Supplement_1):S266–S267. doi:10.1093/schbul/sbaa029.652
   Google Scholar
• Compton MT, Broussard B. The First Episode of Psychosis: A Guide for Young People and Their Families. Revised and updated ed. Oxford University Press; 2021.
   Google Scholar
• van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45(1–2):11–20. doi:10.1016/s0920-9964(99)00224-8
   PubMed Web of Science ®Google Scholar
• van Os J, Reininghaus U. Psychosis as a transdiagnostic and extended phenotype in the general population. World Psychiatry. 2016;15(2):118–124. doi:10.1002/wps.20310
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Walsh BC, Woods SW. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up. Oxford University Press; 2010.
   Google Scholar
• Breitborde NJK, Guirgis H, Stearns W, et al. The Ohio State University Early Psychosis Intervention Center (EPICENTER) step-based care programme for individuals at clinical high risk for psychosis: study protocol for an observational study. BMJ Open. 2020;10(1):e034031. doi:10.1136/bmjopen-2019-034031
   PubMed Web of Science ®Google Scholar
• Hamilton SA, Wastler HM, Moe AM, et al. Symptomatic and functional outcomes among individuals at clinical high risk for psychosis participating in step-based care. Psychiatric Serv. 2023;2023:appi–ps.
   Google Scholar
• McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009;70(9):1206–1212. doi:10.4088/JCP.08r04472
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003;160(8):1396–1404. doi:10.1176/appi.ajp.160.8.1396
   PubMed Web of Science ®Google Scholar
• Perkins D, Lieberman J, Gu H, et al. Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders. Br J Psychiatry. 2004;185(1):18–24. doi:10.1192/bjp.185.1.18
   PubMed Web of Science ®Google Scholar
• Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205–1218. doi:10.1017/S1461145712001277
   PubMed Web of Science ®Google Scholar
• Block JJ. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163(10):1838; author reply 1838. doi:10.1176/ajp.2006.163.10.1838
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Zipursky RB, Perkins D, et al. Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry. 2006;163(5):790–799. doi:10.1176/ajp.2006.163.5.790
   PubMed Web of Science ®Google Scholar
• McGlashan TH, Walsh BC, Woods SW. Structured Interview for Psychosis-risk Syndromes, Version 5.6.1; 2017.
   Google Scholar
• Breitborde NJK, Srihari VH, Woods SW. Review of the operational definition for first-episode psychosis. Early Interv Psychiatry. 2009;3(4):259–265. doi:10.1111/j.1751-7893.2009.00148.x
   PubMed Web of Science ®Google Scholar
• Kessler RC, Amminger GP, Aguilar-Gaxiola S, Alonso J, Lee S, Ustün TB. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20(4):359–364. doi:10.1097/YCO.0b013e32816ebc8c
   PubMed Web of Science ®Google Scholar
• van Os J, Rutten BP, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull. 2008;34(6):1066–1082. doi:10.1093/schbul/sbn117
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Statistical Classification of Diseases and Related Health Problems: ICD-11. 11th ed. World Health Organization; 2019.
   Google Scholar
• Clementz BA, Sweeney JA, Hamm JP, et al. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers. Am J Psychiatry. 2016;173(4):373–384. doi:10.1176/appi.ajp.2015.14091200
   PubMed Web of Science ®Google Scholar
• Tandon R. Antipsychotics in the treatment of schizophrenia: an overview. J Clin Psychiatry. 2011;72(Suppl 1):4–8. doi:10.4088/JCP.10075su1.01
   PubMed Web of Science ®Google Scholar
• Rajapakse T, Garcia-Rosales A, Weerawardene S, Cotton S, Fraser R. Themes of delusions and hallucinations in first-episode psychosis. Early Interv Psychiatry. 2011;5(3):254–258. doi:10.1111/j.1751-7893.2011.00281.x
   PubMed Web of Science ®Google Scholar
• Waters F, Collerton D, Ffytche DH, et al. Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull. 2014;40 Suppl 4(Suppl 4):S233–245. doi:10.1093/schbul/sbu036
   PubMedGoogle Scholar
• Jenkins JH. Diagnostic criteria for schizophrenia and related psychotic disorders: integration and suppression of cultural evidence in DSM-IV. Transcult Psychiatry. 1998;35(3):357–376. doi:10.1177/136346159803500303
   Google Scholar
• Andreasen NC, Arndt S, Alliger R, Miller D, Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Arch Gen Psychiatry. 1995;52(5):341–351. doi:10.1001/archpsyc.1995.03950170015003
   PubMed Web of Science ®Google Scholar
• Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33(4):1013–1022. doi:10.1093/schbul/sbl057
   PubMed Web of Science ®Google Scholar
• Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry. 1982;39(7):784–788. doi:10.1001/archpsyc.1982.04290070020005
   PubMed Web of Science ®Google Scholar
• Thorup A, Petersen L, Jeppesen P, et al. Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial. Schizophr Res. 2005;79(1):95–105. doi:10.1016/j.schres.2004.12.020
   PubMed Web of Science ®Google Scholar
• Millan MJ, Fone K, Steckler T, Horan WP. Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. Eur Neuropsychopharmacol. 2014;24(5):645–692. doi:10.1016/j.euroneuro.2014.03.008
   PubMed Web of Science ®Google Scholar
• Engen MJ, Vaskinn A, Melle I, et al. Cognitive and Global Functioning in Patients With First-Episode Psychosis Stratified by Level of Negative Symptoms. A 10-Year Follow-Up Study. Front Psychiatry. 2022;13:841057. doi:10.3389/fpsyt.2022.841057
   PubMed Web of Science ®Google Scholar
• Edwards J, McGorry PD, Waddell FM, Harrigan SM. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr Res. 1999;40(2):147–158. doi:10.1016/s0920-9964(99)00043-2
   PubMed Web of Science ®Google Scholar
• Gee B, Hodgekins J, Fowler D, et al. The course of negative symptom in first episode psychosis and the relationship with social recovery. Schizophr Res. 2016;174(1–3):165–171. doi:10.1016/j.schres.2016.04.017
   PubMed Web of Science ®Google Scholar
• Docherty NM. Missing referents, psychotic symptoms, and discriminating the internal from the externalized. J Abnorm Psychol. 2012;121(2):416–423. doi:10.1037/a0026348
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi:10.1093/schbul/13.2.261
   PubMed Web of Science ®Google Scholar
• McGorry PD, Bell RC, Dudgeon PL, Jackson HJ. The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychol Med. 1998;28(4):935–947. doi:10.1017/s0033291798006771
   PubMed Web of Science ®Google Scholar
• McCleery A, Ventura J, Kern RS, et al. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophr Res. 2014;157(1–3):33–39. doi:10.1016/j.schres.2014.04.039
   PubMed Web of Science ®Google Scholar
• Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014;40(4):744–755. doi:10.1093/schbul/sbt085
   PubMed Web of Science ®Google Scholar
• Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72(1):41–51. doi:10.1016/j.schres.2004.09.009
   PubMed Web of Science ®Google Scholar
• Addington J, Saeedi H, Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res. 2005;78(1):35–43. doi:10.1016/j.schres.2005.05.008
   PubMed Web of Science ®Google Scholar
• Breitborde NJK, Meier M. Cognition in first-episode psychosis: from phenomenology to intervention. Curr Psychiatry Rev. 2017;12(4):306–318. doi:10.2174/1573400512666160927145737
   Google Scholar
• Thompson KN, McGorry PD, Harrigan SM. Recovery style and outcome in first-episode psychosis. Schizophr Res. 2003;62(1–2):31–36. doi:10.1016/s0920-9964(02)00428-0
   PubMed Web of Science ®Google Scholar
• Ramu N, Kolliakou A, Sanyal J, Patel R, Stewart R. Recorded poor insight as a predictor of service use outcomes: cohort study of patients with first-episode psychosis in a large mental healthcare database. BMJ Open. 2019;9(6):e028929. doi:10.1136/bmjopen-2019-028929
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Tohen M, Stoll AL, et al. Comorbidity in psychosis at first hospitalization. Am J Psychiatry. 1993;150(5):752–757. doi:10.1176/ajp.150.5.752
   PubMed Web of Science ®Google Scholar
• Wilson RS, Yung AR, Morrison AP. Comorbidity rates of depression and anxiety in first episode psychosis: a systematic review and meta-analysis. Schizophr Res. 2020;216:322–329. doi:10.1016/j.schres.2019.11.035
   PubMed Web of Science ®Google Scholar
• Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Course of substance misuse and daily tobacco use in first-episode psychosis. Schizophr Res. 2006;81(2–3):145–150. doi:10.1016/j.schres.2005.09.010
   PubMed Web of Science ®Google Scholar
• Strakowski SM, Keck PE, McElroy SL, Lonczak HS, West SA. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry. 1995;36(2):106–112. doi:10.1016/s0010-440x(95)90104-3
   PubMed Web of Science ®Google Scholar
• Correll CU, Robinson DG, Schooler NR, et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry. 2014;71(12):1350–1363. doi:10.1001/jamapsychiatry.2014.1314
   PubMed Web of Science ®Google Scholar
• Melle I, Olav Johannesen J, Haahr UH, et al. Causes and predictors of premature death in first-episode schizophrenia spectrum disorders. World Psychiatry. 2017;16(2):217–218. doi:10.1002/wps.20431
   PubMed Web of Science ®Google Scholar
• Ventriglio A, Gentile A, Bonfitto I, et al. Suicide in the Early Stage of Schizophrenia. Front Psychiatry. 2016;7:116. doi:10.3389/fpsyt.2016.00116
   PubMed Web of Science ®Google Scholar
• Moe AM, Llamocca E, Wastler HM, et al. Risk Factors for Deliberate Self-harm and Suicide Among Adolescents and Young Adults With First-Episode Psychosis. Schizophr Bull. 2022;48(2):414–424. doi:10.1093/schbul/sbab123
   PubMed Web of Science ®Google Scholar
• Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol. 2010;24(4 Suppl):81–90. doi:10.1177/1359786810385490
   PubMed Web of Science ®Google Scholar
• Kurdyak P, Mallia E, de Oliveira C, et al. Mortality After the First Diagnosis of Schizophrenia-Spectrum Disorders: a Population-based Retrospective Cohort Study. Schizophr Bull. 2021;47(3):864–874. doi:10.1093/schbul/sbaa180
   PubMed Web of Science ®Google Scholar
• Miller TJ, McGlashan TH, Woods SW, et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999;70(4):273–287. doi:10.1023/a:1022034115078
   PubMed Web of Science ®Google Scholar
• Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39(11–12):964–971. doi:10.1080/j.1440-1614.2005.01714.x
   PubMed Web of Science ®Google Scholar
• Salazar de Pablo G, Radua J, Pereira J, et al. Probability of Transition to Psychosis in Individuals at Clinical High Risk: an Updated Meta-analysis. JAMA Psychiatry. 2021;78(9):970–978. doi:10.1001/jamapsychiatry.2021.0830
   PubMed Web of Science ®Google Scholar
• Addington J, Liu L, Goldstein BI, et al. Clinical staging for youth at-risk for serious mental illness. Early Interv Psychiatry. 2019;13(6):1416–1423. doi:10.1111/eip.12786
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: a Meta-analytical Stratification. JAMA Psychiatry. 2016;73(2):113–120. doi:10.1001/jamapsychiatry.2015.2324
   PubMed Web of Science ®Google Scholar
• Hall RC. Global assessment of functioning. A modified scale. Psychosomatics. 1995;36(3):267–275. doi:10.1016/S0033-3182(95)71666-8
   PubMed Web of Science ®Google Scholar
• Schultze-Lutter F, Theodoridou A. The concept of basic symptoms: its scientific and clinical relevance. World Psychiatry. 2017;16(1):104–105. doi:10.1002/wps.20404
   PubMed Web of Science ®Google Scholar
• Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58(2):158–164. doi:10.1016/j.euroneuro.2014.03.008
   PubMed Web of Science ®Google Scholar
• Rosen JL, Woods SW, Miller TJ, McGlashan TH. Prospective observations of emerging psychosis. J Nerv Ment Dis. 2002;190(3):133–141. doi:10.1097/00005053-200203000-00001
   PubMed Web of Science ®Google Scholar
• Bora E, Lin A, Wood SJ, Yung AR, McGorry PD, Pantelis C. Cognitive deficits in youth with familial and clinical high risk to psychosis: a systematic review and meta-analysis. Acta Psychiatr Scand. 2014;130(1):1–15. doi:10.1111/acps.12261
   PubMed Web of Science ®Google Scholar
• Addington J, Stowkowy J, Liu L, et al. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019;49(10):1670–1677. doi:10.1017/S0033291718002258
   PubMed Web of Science ®Google Scholar
• Devoe DJ, Braun A, Seredynski T, Addington J. Negative Symptoms and Functioning in Youth at Risk of Psychosis: a Systematic Review and Meta-analysis. Harv Rev Psychiatry. 2020;28(6):341–355. doi:10.1097/HRP.0000000000000273
   PubMed Web of Science ®Google Scholar
• Tarbox SI, Addington J, Cadenhead KS, et al. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Dev Psychopathol. 2013;25(4 Pt 1):1171–1186. doi:10.1017/S0954579413000448
   PubMed Web of Science ®Google Scholar
• Wastler HM, Cowan HR, Hamilton SA, et al. Variability in suicidal ideation during treatment for individuals at clinical high risk for psychosis: the importance of repeated assessment. Early Interv Psychiatry. 2023;17(10):1038–1041. doi:10.1111/eip.13413
   PubMed Web of Science ®Google Scholar
• Wastler HM, Cowan HR, Hamilton SA, et al. Within-Person Relationship between Attenuated Positive Symptoms and Suicidal Ideation among Individuals at Clinical High Risk for Psychosis. Arch Suicide Res. 2023:1–14. doi:10.1080/13811118.2023.2269209
   PubMed Web of Science ®Google Scholar
• Taylor PJ, Hutton P, Wood L. Are people at risk of psychosis also at risk of suicide and self-harm? A systematic review and meta-analysis. Psychol Med. 2015;45(5):911–926. doi:10.1017/S0033291714002074
   PubMed Web of Science ®Google Scholar
• Solmi M, Soardo L, Kaur S, et al. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment. Mol Psychiatry. 2023;28(6):2291–2300. doi:10.1038/s41380-023-02029-8
   PubMed Web of Science ®Google Scholar
• Cannon TD, Yu C, Addington J, et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. Am J Psychiatry. 2016;173(10):980–988. doi:10.1176/appi.ajp.2016.15070890
   PubMed Web of Science ®Google Scholar
• Oliver D, Reilly TJ, Baccaredda Boy O, et al. What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors. Schizophr Bull. 2020;46(1):110–120. doi:10.1093/schbul/sbz039
   PubMed Web of Science ®Google Scholar
• Nelson B, Yuen HP, Lin A, et al. Further examination of the reducing transition rate in ultra high risk for psychosis samples: the possible role of earlier intervention. Schizophr Res. 2016;174(1–3):43–49. doi:10.1016/j.schres.2016.04.040
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Schultze-Lutter F, Cappucciati M, et al. The Dark Side of the Moon: meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis. Schizophr Bull. 2016;42(3):732–743. doi:10.1093/schbul/sbv162
   PubMed Web of Science ®Google Scholar
• Wiltink S, Velthorst E, Nelson B, McGorry PM, Yung AR. Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. Early Interv Psychiatry. 2015;9(3):200–206. doi:10.1111/eip.12105
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43(1):44–47. doi:10.1093/schbul/sbw158
   PubMed Web of Science ®Google Scholar
• Carrión RE, McLaughlin D, Goldberg TE, et al. Prediction of functional outcome in individuals at clinical high risk for psychosis. JAMA Psychiatry. 2013;70(11):1133–1142. doi:10.1001/jamapsychiatry.2013.1909
   PubMed Web of Science ®Google Scholar
• Kwapil TR, Gross GM, Silvia PJ, Raulin ML, Barrantes-Vidal N. Development and psychometric properties of the Multidimensional Schizotypy Scale: a new measure for assessing positive, negative, and disorganized schizotypy. Schizophr Res. 2018;193:209–217. doi:10.1016/j.schres.2017.07.001
   PubMed Web of Science ®Google Scholar
• Stefanis NC, Hanssen M, Smirnis NK, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med. 2002;32(2):347–358. doi:10.1017/s0033291701005141
   PubMed Web of Science ®Google Scholar
• Addington J, Woods SW, Yung AR, Calkins ME, Fusar-Poli P. Harmonizing the structured interview for psychosis-risk syndromes (SIPS) and the comprehensive assessment of at-risk mental states (CAARMS): an initial approach. Early Interv Psychiatry. 2023. doi:10.1111/eip.13401
   Web of Science ®Google Scholar
• Gross G, Huber G, Klosterkötter J, Linz M. BSABS: Bonn Scale for the Assessment of Basic Symptoms. 1st English ed. ShakerVerlag; 2008.
   Google Scholar
• Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J. Schizophrenia Proneness Instrument, Adult Version (SPI-A). Giovanni Fioriti Editore; 2007.
   Google Scholar
• Schultze-Lutter F, Koch E. Schizophrenia Proneness Instrument: Child and Youth Version (SPI-CY). Fioriti; 2010.
   Google Scholar
• First MB, Williams JBW, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5-Research Version. Am Psychiatr Assoc. 2015;2015:1.
   Google Scholar
• Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35(7):837–844. doi:10.1001/archpsyc.1978.01770310043002
   PubMed Web of Science ®Google Scholar
• Kaufman J, Schweder AE. The Schedule for Affective Disorders and Schizophrenia for School-Age Children: present and Lifetime version (K-SADS-PL). In: Comprehensive Handbook of Psychological Assessment. Vol. 2. John Wiley & Sons, Inc.; 2004:247–255.
   Google Scholar
• Loewy RL, Pearson R, Vinogradov S, Bearden CE, Cannon TD. Psychosis risk screening with the Prodromal Questionnaire — brief Version (PQ-B). Schizophr Res. 2011;129(1):42–46. doi:10.1016/j.schres.2011.03.029
   PubMed Web of Science ®Google Scholar
• Addington J, Stowkowy J, Weiser M. Screening tools for clinical high risk for psychosis. Early Interv Psychiatry. 2015;9(5):345–356. doi:10.1111/eip.12193
   PubMed Web of Science ®Google Scholar
• Miller TJ, Cicchetti D, Markovich PJ, McGlashan TH, Woods SW. The SIPS screen: a brief self-report screen to detect the schizophrenia prodrome. Schizophr Res. 2004;70:78.
   Web of Science ®Google Scholar
• Ord LM, Myles-Worsley M, Blailes F, Ngiralmau H. Screening for prodromal adolescents in an isolated high-risk population. Schizophr Res. 2004;71(2–3):507–508. doi:10.1016/j.schres.2004.03.014
   PubMed Web of Science ®Google Scholar
• Brodey BB, Girgis RR, Favorov OV, et al. The Early Psychosis Screener (EPS): quantitative validation against the SIPS using machine learning. Schizophr Res. 2018;197:516–521. doi:10.1016/j.schres.2017.11.030
   PubMed Web of Science ®Google Scholar
• Woods SW, Parker S, Kerr MJ, et al. Development of the PSYCHS: positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. medRxiv. 2023. doi:10.1101/2023.04.29.23289226
   Google Scholar
• Schultze-Lutter F, Klosterkötter J, Ruhrmann S. Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms. Schizophr Res. 2014;154(1–3):100–106. doi:10.1016/j.schres.2014.02.010
   PubMed Web of Science ®Google Scholar
• Carpenter WT, van Os J. Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry. 2011;168(5):460–463. doi:10.1176/appi.ajp.2011.10121816
   PubMed Web of Science ®Google Scholar
• Corcoran CM, First MB, Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk–benefit analysis. Schizophr Res. 2010;120(1–3):16–22. doi:10.1016/j.schres.2010.03.018
   PubMed Web of Science ®Google Scholar
• Woods SW, Walsh BC, Saksa JR, McGlashan TH. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophr Res. 2010;123(2–3):199–207. doi:10.1016/j.schres.2010.08.012
   PubMed Web of Science ®Google Scholar
• Yang LH, Link BG, Ben-David S, et al. Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis. Schizophr Res. 2015;168(1–2):9–15. doi:10.1016/j.schres.2015.08.004
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33;quiz 34–57.
   Google Scholar
• Hamilton SA, Parris CJ, Breitborde NJK, Stearns WH. Psychotic-spectrum disorders in children and adolescents. In: Developmental-Behavioral Pediatrics E-Book. 5th ed. Elsevier Health Sciences. 2022 :549–558.
   Google Scholar
• Cassano GB, Pini S, Saettoni M, Rucci P, Dell’Osso L. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders. J Clin Psychiatry. 1998;59(2):60–68. doi:10.4088/jcp.v59n0204
   PubMed Web of Science ®Google Scholar
• Bleuler E. Dementia Praecox or the Group of Schizophrenias (J. Zinkin, Translation, 1950). International Universities Press; 1911.
   Google Scholar
• Wilson C, Kline E, Reeves G, Anthony L, Schiffman J. Blurred Edges: evolving Concepts of Autism Spectrum Disorders and Schizophrenia. Adolesc Psychiatry. 2014;4(3):133–146. doi:10.2174/221067660403140912161312
   Google Scholar
• Jutla A, Foss‐Feig J, Veenstra‐VanderWeele J. Autism spectrum disorder and schizophrenia: an updated conceptual review. Autism Res. 2022;15(3):384–412. doi:10.1002/aur.2659
   PubMed Web of Science ®Google Scholar
• Wilson CS, Anthony L, Kenworthy L, et al. Feasibility of psychosis risk assessment for adolescents diagnosed with autism. Autism. 2020;24(4):834–850. doi:10.1177/1362361320909173
   PubMed Web of Science ®Google Scholar
• Dossetor DR. ‘All That Glitters Is Not Gold’: misdiagnosis of Psychosis in Pervasive Developmental Disorders — a Case Series. Clin Child Psychol Psychiatry. 2007;12(4):537–548. doi:10.1177/1359104507078476
   PubMedGoogle Scholar
• Ribolsi M, Fiori Nastro F, Pelle M, et al. Recognizing Psychosis in Autism Spectrum Disorder. Front Psychiatry. 2022;13:768586. doi:10.3389/fpsyt.2022.768586
   PubMedGoogle Scholar
• Van Schalkwyk GI, Peluso F, Qayyum Z, McPartland JC, Volkmar FR. Varieties of misdiagnosis in ASD: an illustrative case series. J Autism Dev Disord. 2015;45(4):911–918. doi:10.1007/s10803-014-2239-y
   PubMed Web of Science ®Google Scholar
• Kincaid DL, Doris M, Shannon C, Mulholland C. What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review. Psychiatry Res. 2017;250:99–105. doi:10.1016/j.psychres.2017.01.017
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zheng P, Zou X. Association between schizophrenia and autism spectrum disorder: a systematic review and meta-analysis. Autism Res. 2018;11(8):1110–1119. doi:10.1002/aur.1977
   PubMed Web of Science ®Google Scholar
• Carroll LS, Owen MJ. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med. 2009;1(10):102. doi:10.1186/gm102
   PubMedGoogle Scholar
• Vaquerizo-Serrano J, Salazar de Pablo G, Singh J, Santosh P. Autism Spectrum Disorder and Clinical High Risk for Psychosis: a Systematic Review and Meta-analysis. J Autism Dev Disord. 2022;52(4):1568–1586. doi:10.1007/s10803-021-05046-0
   PubMed Web of Science ®Google Scholar
• De Haan L, Schirmbeck F, Zink M, eds.. Obsessive-Compulsive Symptoms in Schizophrenia. Springer International Publishing; 2015. doi:10.1007/978-3-319-12952-5
   Google Scholar
• Achim AM, Maziade M, Raymond E, Olivier D, Mérette C, Roy M-A. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37(4):811–821. doi:10.1093/schbul/sbp148
   PubMed Web of Science ®Google Scholar
• Bendall S, Jackson HJ, Hulbert CA, McGorry PD. Childhood Trauma and Psychotic Disorders: a Systematic, Critical Review of the Evidence. Schizophr Bull. 2007;34(3):568–579. doi:10.1093/schbul/sbm121
   PubMed Web of Science ®Google Scholar
• OConghaile A, DeLisi LE. Distinguishing schizophrenia from posttraumatic stress disorder with psychosis. CurrOpin Psychiatry. 2015;28(3):249–255. doi:10.1097/YCO.0000000000000158
   Google Scholar
• Pierre JM. Hallucinations in nonpsychotic disorders: toward a differential diagnosis of “hearing voices. Harv Rev Psychiatry. 2010;18(1):22–35. doi:10.3109/10673220903523706
   PubMed Web of Science ®Google Scholar
• Gearon JS, Bellack AS, Tenhula WN. Preliminary Reliability and Validity of the Clinician-Administered PTSD Scale for Schizophrenia. J Consult Clin Psychol. 2004;72(1):121–125. doi:10.1037/0022-006X.72.1.121
   PubMed Web of Science ®Google Scholar
• Lu W, Yanos PT, Waynor W, et al. Psychometric properties of post-traumatic stress disorder (PTSD) checklist for DSM-5 in persons with serious mental illness. Eur J Psychotraumatol. 2022;13(1):2038924. doi:10.1080/20008198.2022.2038924
   PubMed Web of Science ®Google Scholar
• Barlow DH, Farchione TJ, Sauer-Zavala S, et al. Unified Protocol for Transdiagnostic Treatment of Emotional Disorders: Therapist Guide. Second ed. Oxford University Press; 2018.
   Google Scholar
• Resick PA, Monson CM, Chard KM. Cognitive Processing Therapy for PTSD: A Comprehensive Manual. The Guilford Press; 2017.
   Google Scholar
• Breitborde NJK, Moe AM. Early Intervention in Psychosis in the United States: from Science to Policy Reform. Policy Insights Behav Brain Sci. 2017;4(1):79–87. doi:10.1177/2372732216683965
   Google Scholar
• Moe AM, Rubinstein EB, Gallagher CJ, Weiss DM, Stewart A, Breitborde NJ. Improving access to specialized care for first-episode psychosis: an ecological model. RMHP. 2018;11:127–138. doi:10.2147/RMHP.S131833
   Google Scholar
• Kline E, Schiffman J. Psychosis risk screening: a systematic review. Schizophr Res. 2014;158(1–3):11–18. doi:10.1016/j.schres.2014.06.036
   PubMed Web of Science ®Google Scholar
• Bebbington P, Nayani T. The psychosis screening questionnaire. Int J Methods Psychiatr Res. 1995;5(1):11–19.
   Web of Science ®Google Scholar
• Heuvelman H, Nazroo J, Rai D. Investigating ethnic variations in reporting of psychotic symptoms: a multiple-group confirmatory factor analysis of the Psychosis Screening Questionnaire. Psychol Med. 2018;48(16):2757–2765. doi:10.1017/S0033291718000399
   PubMed Web of Science ®Google Scholar
• Owoso A, Ndetei DM, Mbwayo AW, Mutiso VN, Khasakhala LI, Mamah D. Validation of a modified version of the PRIME screen for psychosis-risk symptoms in a non-clinical Kenyan youth sample. Compr Psychiatry. 2014;55(2):380–387. doi:10.1016/j.comppsych.2013.10.004
   PubMed Web of Science ®Google Scholar
• Savill M, D’Ambrosio J, Cannon TD, Loewy RL. Psychosis risk screening in different populations using the Prodromal Questionnaire: a systematic review. Early Interv Psychiatry. 2018;12(1):3–14. doi:10.1111/eip.12446
   PubMed Web of Science ®Google Scholar
• Simeonova DI, Nguyen T, Walker EF. Psychosis risk screening in clinical high-risk adolescents: a longitudinal investigation using the Child Behavior Checklist. Schizophr Res. 2014;159(1):7–13. doi:10.1016/j.schres.2014.07.046
   PubMed Web of Science ®Google Scholar
• Thompson E, Kline E, Reeves G, Pitts SC, Bussell K, Schiffman J. Using parent and youth reports from the Behavior Assessment System for Children, Second Edition to identify individuals at clinical high-risk for psychosis. Schizophr Res. 2014;154(1–3):107–112. doi:10.1016/j.schres.2014.02.009
   PubMed Web of Science ®Google Scholar
• Kennedy L, Johnson KA, Cheng J, Woodberry KA. A Public Health Perspective on Screening for Psychosis Within General Practice Clinics. Front Psychiatry. 2020;10:1025. doi:10.3389/fpsyt.2019.01025
   PubMed Web of Science ®Google Scholar
• Bernardin F, Gauld C, Martin VP, Laprévote V, Dondé C. The 68 symptoms of the clinical high risk for psychosis: low similarity among fourteen screening questionnaires. Psychiatry Res. 2023;330:115592. doi:10.1016/j.psychres.2023.115592
   PubMed Web of Science ®Google Scholar
• Ellman LM, Schiffman J, Mittal VA. Community Psychosis Risk Screening: an Instrument Development Investigation. J Psychiatr Brain Sci. 2020;5:e200019. doi:10.20900/jpbs.20200019
   PubMedGoogle Scholar
• Millman ZB, Rakhshan Rouhakhtar PJ, DeVylder JE, et al. Evidence for Differential Predictive Performance of the Prime Screen Between Black and White Help-Seeking Youths. Psychiatr Serv. 2019;70(10):907–914. doi:10.1176/appi.ps.201800536
   PubMed Web of Science ®Google Scholar
• Schiffman J, Ellman LM, Mittal VA. Individual Differences and Psychosis-Risk Screening: practical Suggestions to Improve the Scope and Quality of Early Identification. Front Psychiatry. 2019;10:6. doi:10.3389/fpsyt.2019.00006
   PubMed Web of Science ®Google Scholar
• Wilson C, Smith ME, Thompson E, et al. Context matters: the impact of neighborhood crime and paranoid symptoms on psychosis risk assessment. Schizophr Res. 2016;171(1–3):56–61. doi:10.1016/j.schres.2016.01.007
   PubMed Web of Science ®Google Scholar
• Wolny J, Moussa-Tooks AB, Bailey AJ, O’Donnell BF, Hetrick WP. Race and self-reported paranoia: increased item endorsement on subscales of the SPQ. Schizophr Res. 2023;253:30–39. doi:10.1016/j.schres.2021.11.034
   PubMed Web of Science ®Google Scholar
• Addington D. The First Episode Psychosis Services Fidelity Scale 1.0: review and Update. Schizophrenia Bulletin Open. 2021;2(1):sgab007. doi:10.1093/schizbullopen/sgab007
   Google Scholar
• Howes OD, Whitehurst T, Shatalina E, et al. The clinical significance of duration of untreated psychosis: an umbrella review and random-effects meta-analysis. World Psychiatry. 2021;20(1):75–95. doi:10.1002/wps.20822
   PubMed Web of Science ®Google Scholar
• Lloyd-Evans B, Crosby M, Stockton S, et al. Initiatives to shorten duration of untreated psychosis: systematic review. Br J Psychiatry. 2011;198(4):256–263. doi:10.1192/bjp.bp.109.075622
   PubMed Web of Science ®Google Scholar
• Oliver D, Davies C, Crossland G, et al. Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies. Schizophr Bull. 2018;44(6):1362–1372. doi:10.1093/schbul/sbx166
   PubMed Web of Science ®Google Scholar
• Estradé A, Salazar de Pablo G, Zanotti A, Wood S, Fisher HL, Fusar-Poli P. Public health primary prevention implemented by clinical high-risk services for psychosis. Transl Psychiatry. 2022;12(1):43. doi:10.1038/s41398-022-01805-4
   PubMed Web of Science ®Google Scholar
• McIlwaine SV, Jordan G, Pruessner M, et al. Does an integrated outreach intervention targeting multiple stages of early psychosis improve the identification of individuals at clinical high risk? Early Interv Psychiatry. 2019;13(4):989–992. doi:10.1111/eip.12750
   PubMed Web of Science ®Google Scholar
• López SR, Kopelowicz A, Ullman J, et al. Toward reducing the duration of untreated psychosis in a Latinx community. J Consult Clin Psychol. 2022;90(10):815–826. doi:10.1037/ccp0000729
   PubMed Web of Science ®Google Scholar
• Lynch S, McFarlane WR, Joly B, et al. Early Detection, Intervention and Prevention of Psychosis Program: community Outreach and Early Identification at Six U.S. Sites. Psychiatr Serv. 2016;67(5):510–516. doi:10.1176/appi.ps.201300236
   PubMed Web of Science ®Google Scholar
• Ramsay Wan C, Broussard B, Haggard P, Compton MT. Criminal justice settings as possible sites for early detection of psychotic disorders and reducing treatment delay. Psychiatr Serv. 2014;65(6):758–764. doi:10.1176/appi.ps.201300206
   PubMed Web of Science ®Google Scholar